NeuroPace, Inc. provided earnings guidance for the year 2024. Total revenue to range between $73 million and $77 million, representing growth of 12% to 18% over 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.485 USD | +0.39% | -0.06% | -37.67% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.67% | 186M | |
+6.79% | 218B | |
+10.04% | 189B | |
+27.76% | 151B | |
+32.14% | 113B | |
-0.15% | 64.02B | |
+13.88% | 52.6B | |
+1.85% | 49.85B | |
-5.78% | 37.89B | |
+0.54% | 34.92B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- NeuroPace, Inc. Provides Earnings Guidance for the Year 2024